Financial News
Latest News about DMTTF
Recent news which mentions DMTTF
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
From Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Tickers
DMTTF
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
From Benzinga
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
February 15, 2023
Tickers
DMTTF
From Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
Tickers
DMTTF
From Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Tickers
DMTTF
From Benzinga
Comparing Psychedelics' Administration Routes: Are Intramuscular Injections More Effective Than Intravenous?
January 11, 2023
Tickers
DMTTF
From Benzinga
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
December 28, 2022
From Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
December 22, 2022
Tickers
DMTTF
From Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Tickers
DMTTF
From Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
From Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
From Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
From Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
From Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
October 21, 2022
From Benzinga
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
October 19, 2022
Tickers
DMTTF
From Benzinga
Psychedelic Stock Gainers And Losers From October 18, 2022
October 18, 2022
From Benzinga
Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway
October 18, 2022
Tickers
DMTTF
From Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
October 14, 2022
From Benzinga
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
October 11, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 6, 2022
October 06, 2022
From Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
October 04, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
